巖山科技(002195.SZ):在醫療領域RockAI已與行業合作方合作開發了生成式智慧病歷系統
格隆匯1月7日丨巖山科技(002195.SZ)在投資者互動平台表示,“人工智能+”代表一種新範式,即將人工智能技術與各行各業、各種應用場景有機結合,以創造更多價值。公司旗下巖芯數智自主研發的Yan 1.3大模型,應用硬件設備從機器人、手機、個人電腦、樹莓派等繼續應用到無人機、Mini主機等設備。目前,在醫療領域RockAI已與行業合作方合作開發了生成式智慧病歷系統。未來RockAI在進一步做好基礎技術創新的同時也會通過外部合作來強化商業化應用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.